3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
77
Burkitt Lymphoma
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Leukemia, Biphenotypic, Acute
16
Myelodysplastic Syndromes
14
Leukemia
11
Myeloproliferative Disorders
7
Lymphoma, Mantle-Cell
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Recurrence
5
Leukemia, Myelomonocytic, Chronic
5
Sarcoma, Myeloid
4
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Blast Crisis
4
Leukemia, Monocytic, Acute
3
Hematologic Neoplasms
3
Down Syndrome
3
Lymphoma, T-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Myeloid
2
Hodgkin Disease
2
Anemia, Refractory, with Excess of Blasts
2
Thrombocythemia, Essential
1
Targeted Therapy
1
Interventions
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Cyclophosphamide
2
Busulfan
2
Azacitidine
2
venetoclax
1
pevonedistat
1
fludarabine
1
fedratinib
1
Transplantation
1
Sirolimus
1
Radiotherapy
1
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
1
Methotrexate
1
Melphalan
1
Etoposide
1
Cyclosporine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Neutrophilic, Chronic
×
Cytarabine
×
90 days
×
Clear all
No trials found.